Zetagen Therapeutics, a clinical‑stage biopharmaceutical company developing novel therapies for primary and metastatic breast cancer, today announced preliminary topline results from its Phase 2a ...
For more than 175 years, The Associated Press has gathered, verified and published election results in thousands of races across the United States. AP’s commitment to delivering precise and ...
ORLANDO, FL / ACCESS Newswire / June 5, 2026 / RedChip Companies will host an investor webinar with Calidi Biotherapeutics, ...
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.
AP delivers exclusive and rare account from inside an African hotel where asylum seekers deported by the U.S. are imprisoned Dakar newsperson Monika Pronczuk has been reporting for months on secretive ...
Organon (NYSE: OGN) today announced the US Food and Drug Administration (FDA) approval of the supplemental Biologics License Application (sBLA) for TOFIDENCE ® (tocilizumab-bavi) injection, for ...
Belite Bio, Inc. engages in the research and development of drugs. It focuses on the treatment of eye diseases involving retinal degeneration such as atrophic age-related macular degeneration and ...
About Tevogen Bio Holdings Inc. Tevogen Bio Holdings, Inc. is a clinical-stage specialty immunotherapy company, which engages in the provision of off-the-shelf therapies for the treatment of ...
Cell biology is the discipline of biological sciences that studies the structure, physiology, growth, reproduction and death of cells. Research in cell biology uses microscopic and molecular tools and ...
Developmental biology is the field of biology that studies the processes by which multicellular organisms grow and develop, controlled by their genes. Knowledge of normal developmental processes can ...
Fidelity Investments is one of the largest mutual fund companies in the U.S. Headquartered in Boston, the firm offers financial products and services to more than 40 million individuals. Founded by ...
Non-covalent targeting of KEAP1 by capsaicin provides a reversible and safe NRF2 agonist for treating oxidative damage.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results